MedPath

Prospective cohort study of germline variant carriers with BRCA1 and BRCA2 (JGOG3024/KGOG3055)

Not Applicable
Recruiting
Conditions
Hereditary breast and ovarian cancer BRCA1 and/or BRCA2 variant carriers ovarian, fallopian tube, and peritoneal carcinoma
Registration Number
JPRN-UMIN000028740
Lead Sponsor
Japanese Gynecologic Oncology Group(JGOG)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
1600
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Women without ovarian or fallopian tube cancer at the time of informed consent. (2) Women previously diagnosed with ovarian, fallopian tube, or peritoneal cancer, and not excluding those with a personal history of breast cancer development. (3)Other individuals considered inappropriate for involvement in this study by the investigator.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath